| Name | Title | Contact Details |
|---|---|---|
Robert Severo |
Vice President of Risk and Analytics and Chief Compliance Officer | Profile |
Ashley Caldwell |
General Counsel | Profile |
Abigail Johnson |
Managing Director and General Counsel | Profile |
Quadrant Private Wealth is an independent, boutique wealth management firm, owned by its partners and built especially for our clients. Quadrant offers a complete spectrum of investment strategies geared towards preserving and growing wealth. We strive to protect our clients from what can go wrong by focusing on managing risk. Our private wealth advisors consider a broad range of investments that include traditional and non-traditional asset classes. We`ll evaluate your individual circumstances, risk tolerance, goals, and future aspirations to create a sophisticated investment plan that fits your needs. Quadrant`s private wealth advisors will help you determine the best solutions with regard to estate planning, wealth transfer, and business succession planning.
M.R. Beal & Company is a New York, NY-based company in the Financial Services sector.
Rediger Investment Corporation is a Burbank, CA-based company in the Financial Services sector.
The Broe Group is a Denver-based private investment firm focusing on real estate, transportation, and energy. We acquire, develop and manage commercial real estate assets, own and operate diverse transportation businesses centered on rail, maritime and terminal management, and explore natural resources--all as independent business platforms. Each has its own dynamic growth strategy. Over the last 40 years, we`ve built a multi-billion dollar asset base and a world-class management team through direct investment in and development of each of these business groups.
BullFrog AI is an investor-backed company determined to become the undisputed leader in precision medicine. Our mission is to find the link between therapies and patients, and improve their lives. Using our proprietary technology platform, we aim to predict which patients will benefit from which medications, effectively improving clinical outcomes and eliminating the problem of trial-and-error prescriptions. We have an exceptional team of life science industry leaders, AI technologists, scientists, physicians and advisors determined to help BullFrog AI revolutionize drug development. Through our partnership with one of the most prestigious research institutions in the world, we take pride in technology innovation by staying on the cutting edge of AI.